Examkin

Soru

Zorluk: OrtaPreventive Care and Screening

An established patient, a 63-year-old biological male, schedules an ambulatory telehealth appointment to discuss his health maintenance plan before a planned cross-country relocation. His past medical history is significant for chronic obstructive pulmonary disease (COPD), obesity (BMI 33 kg/m²), and a prior hepatitis C infection that was successfully treated with direct-acting antivirals five years ago. He currently smokes half a pack of cigarettes daily and has done so since age 18. Medical records indicate he underwent a screening colonoscopy at age 54, which was unremarkable. A lipid panel and hemoglobin A1c obtained last week are within normal limits. He received an annual influenza vaccination two months ago and a Tdap booster three years ago. He has not received any other adult vaccines. Which of the following preventive interventions are indicated for this patient at this time? (Select all that apply)

  1. Annual low-dose computed tomography of the chestCevap
  2. Administration of a 20-valent pneumococcal conjugate vaccineCevap
  3. C
    Screening ultrasound of the abdominal aorta
  4. D
    Repeat screening colonoscopy
  5. E
    Hepatitis C virus antibody testing

Cevap

The indicated interventions for this patient are annual low-dose computed tomography of the chest and administration of a 20-valent pneumococcal conjugate vaccine.
The correct preventive interventions include low-dose computed tomography (LDCT) of the chest and a pneumococcal conjugate vaccine. LDCT is recommended by the USPSTF for adults aged 50 to 80 years with at least a 20 pack-year smoking history who currently smoke or have quit within the last 15 years; this patient meets all criteria with a 22.5 pack-year history. Additionally, the ACIP recommends pneumococcal vaccination for all adults aged 65 and older, but also for adults aged 19 to 64 years with specific underlying medical conditions. The patient's chronic obstructive pulmonary disease (COPD) qualifies him for the pneumococcal vaccine prior to age 65.

Adım Adım Çözüm

1
Calculate the patient's smoking pack-year history.
The patient has smoked 0.5 packs per day for 45 years (from age 18 to 63), resulting in a 22.5 pack-year history.
Accurate pack-year calculation is necessary to determine eligibility for lung cancer screening.
2
Evaluate the patient for lung cancer screening criteria.
The patient is between 50-80 years old, has a >20 pack-year smoking history, and is a current smoker. Low-dose computed tomography of the chest is indicated.
USPSTF guidelines mandate these specific demographic and historical criteria for annual lung cancer screening.
3
Assess the patient's vaccination needs based on age and comorbidities.
Although under 65, the patient has COPD, which is a qualifying underlying medical condition for pneumococcal vaccination. The 20-valent pneumococcal conjugate vaccine is indicated.
ACIP guidelines require risk-stratification for adults aged 19-64 to determine pneumococcal vaccine eligibility.
4
Analyze age and timeline criteria for the remaining screening options.
Abdominal aortic aneurysm screening is deferred until age 65. The next screening colonoscopy is deferred until age 64 (10 years after a normal exam).
Preventive screening must strictly adhere to upper and lower age limits as well as established testing intervals.
5
Determine the appropriate management for the patient's prior hepatitis C infection.
Routine HCV antibody testing is excluded because his antibodies will remain positive for life post-treatment.
Understanding the serological footprint of treated infectious diseases prevents unnecessary and confusing downstream testing.

Anahtar Kavram

Application of age-specific, interval-specific, and comorbidity-modified preventive screening and immunization guidelines.
Bu soruyu puanla

Konular

Preventive Care and Screening

Bu konudan daha fazla soru